29 February 2024 false Taxfiler 2024.6 14636158 business:PrivateLimitedCompanyLtd 2024-02-29 2025-02-28 14636158 2024-02-28 14636158 2024-02-29 2025-02-28 14636158 business:AuditExemptWithAccountantsReport 2024-02-29 2025-02-28 14636158 business:FilletedAccounts 2024-02-29 2025-02-28 14636158 2025-02-28 14636158 business:Director1 2024-02-29 2025-02-28 14636158 business:Director2 2024-02-29 2025-02-28 14636158 business:Director3 2024-02-29 2025-02-28 14636158 business:RegisteredOffice 2024-02-29 2025-02-28 14636158 2024-02-28 14636158 core:WithinOneYear 2025-02-28 14636158 core:WithinOneYear 2024-02-28 14636158 core:AfterOneYear 2025-02-28 14636158 core:AfterOneYear 2024-02-28 14636158 core:ShareCapital core:PreviouslyStatedAmount 2025-02-28 14636158 core:ShareCapital core:PreviouslyStatedAmount 2024-02-28 14636158 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-02-28 14636158 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-02-28 14636158 core:PreviouslyStatedAmount 2025-02-28 14636158 core:PreviouslyStatedAmount 2024-02-28 14636158 business:SmallEntities 2024-02-29 2025-02-28 14636158 countries:EnglandWales 2024-02-29 2025-02-28 14636158 core:FurnitureFittings 2024-02-29 2025-02-28 14636158 core:Goodwill 2024-02-28 14636158 core:Goodwill 2025-02-28 14636158 core:Goodwill 2024-02-29 2025-02-28 14636158 core:FurnitureFittings 2024-02-28 14636158 core:FurnitureFittings 2025-02-28 14636158 core:AcceleratedTaxDepreciationDeferredTax 2025-02-28 14636158 core:AcceleratedTaxDepreciationDeferredTax 2024-02-28 14636158 2023-02-01 14636158 2023-02-02 2024-02-28 14636158 business:OrdinaryShareClass1 2024-02-29 2025-02-28 14636158 business:OrdinaryShareClass1 2023-02-02 2024-02-28 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 14636158 (England and Wales)
Mba Pharma Ltd Unaudited accounts for the period from 29 February 2024 to 28 February 2025
Mba Pharma Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Mba Pharma Ltd Company Information for the period from 29 February 2024 to 28 February 2025
Directors
Muzammal Batool Mohammed Bilaal Mughal Mohammed Ashraf Mughal
Company Number
14636158 (England and Wales)
Registered Office
199 Moor Green Lane Birmingham West Midlands B13 8NT England
Accountants
Mayfield 1st Floor, 5 Highgate Business Centre Highgate Road Birmingham B12 8EA
- 3 -
Mba Pharma Ltd Statement of financial position as at 28 February 2025
2025
2024
Notes
£
£
Fixed assets
Intangible assets
4
202,520
225,665
Tangible assets
5
1,687
2,250
204,207
227,915
Current assets
Inventories
35,623
45,798
Debtors
6
15,744
12,618
Cash at bank and in hand
53,892
18,963
105,259
77,379
Creditors: amounts falling due within one year
7
(109,254)
(55,657)
Net current (liabilities)/assets
(3,995)
21,722
Total assets less current liabilities
200,212
249,637
Creditors: amounts falling due after more than one year
8
(203,664)
(282,035)
Provisions for liabilities
Deferred tax
9
(321)
(428)
Net liabilities
(3,773)
(32,826)
Capital and reserves
Called up share capital
10
320
320
Profit and loss account
(4,093)
(33,146)
Shareholders' funds
(3,773)
(32,826)
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 13 October 2025 and were signed on its behalf by
Mohammed Ashraf Mughal Director Company Registration No. 14636158
- 4 -
Mba Pharma Ltd Notes to the Accounts for the period from 29 February 2024 to 28 February 2025
1
Statutory information
Mba Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 14636158. The registered office is 199 Moor Green Lane, Birmingham, West Midlands, B13 8NT, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
25% Reducing Balance
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Goodwill
£
Cost
At 29 February 2024
231,451
At 28 February 2025
231,451
Amortisation
At 29 February 2024
5,786
Charge for the period
23,145
At 28 February 2025
28,931
Net book value
At 28 February 2025
202,520
At 28 February 2024
225,665
- 5 -
Mba Pharma Ltd Notes to the Accounts for the period from 29 February 2024 to 28 February 2025
5
Tangible fixed assets
Fixtures & fittings
£
Cost or valuation
At cost
At 29 February 2024
3,000
At 28 February 2025
3,000
Depreciation
At 29 February 2024
750
Charge for the period
563
At 28 February 2025
1,313
Net book value
At 28 February 2025
1,687
At 28 February 2024
2,250
6
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
15,744
12,618
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
19,200
-
Trade creditors
79,002
54,966
Taxes and social security
7,592
691
Other creditors
3,460
-
109,254
55,657
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans
148,133
173,596
Loans from directors
55,531
108,439
203,664
282,035
- 6 -
Mba Pharma Ltd Notes to the Accounts for the period from 29 February 2024 to 28 February 2025
9
Deferred taxation
2025
2024
£
£
Accelerated capital allowances
321
428
2025
2024
£
£
Provision at start of period
428
-
(Credited)/charged to the profit and loss account
(107)
428
Provision at end of period
321
428
10
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
320 Ordinary shares of £1 each
320
320
11
Average number of employees
During the period the average number of employees was 8 (2024: 4).
- 7 -